Open source drug discovery gets its day in the sun

10/24/2013 | Xconomy

Merck, Johnson & Johnson and Sanofi recently launched open source drug development projects that "represent a sea change in the pre-competitive landscape for pharmaceutical development," writes John Wilbanks, a senior fellow at FasterCures and chief commons officer at Sage Bionetworks. The open source movement in drug discovery is being driven by massive public investment in health and biology, as well as governmental and institutional momentum to open knowledge bases for reuse and recombination, Wilbanks writes. "This level of progress would have been unthinkable just a decade ago at the height of the first genomics bubble," he writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT